Skip To Content

Resources

Waltham, MA, USA (November 10, 2025)—ACD/Labs is pleased to share that Revvity, Inc. has entered into a definitive agreement to acquire ACD/Labs. The acquisition will expand the breadth and depth of Revvity Signals’ solutions and bridge the gap between analytical data and actionable insights. “For more than three decades, our scientists, informaticians, and software developers...

Pfizer’s 5 year data management journey has given them a global knowledgebase that manages chemical and analytical data across various workflows. Scientists are accessing data and saving time. Learn how ACD/Labs technologies are enabling their digital evolution strategy.

Takeda has invested significant time and effort in digitalizing and automating R&D. In synthetic molecule process development (SMPD) this involved building up high-throughput experimentation (HTE) and automation capabilities to accelerate process optimization. Join Adrian Ramirez Galilea, Associate Director of Automation & HTE at Takeda, as he shares his experience and insights. He will discuss: How...

Digitalization is transforming research and development across pharma, biopharma, and chemical sciences. From predictive modeling to automated and digitalized workflows, scientists are finding innovative ways to bring together data, tools, and expertise to drive innovation. Join us as we bring together leading researchers and industry experts to explore practical applications of digital tools in real-world...